What do Martin Shkreli, the co founder of 10 billion dollar pharma co., hedge funds and day traders have in common?
The turnaround is in its infancy, but has the ability to run
The device is great, but the trial results could disappoint.
Are you being Gaslit?, Thinking IS working, and reviewing Myomo, Performant, and Semler.
A long term stock limited by capacity, building a surgical platform with an exciting drug delivery business, new innovations on the horizon, too…
ZYXI was one of the biggest winners over the last five years nearly returning 100x: what did it look and feel like along the way?
Plus some thoughts on Specialists, Individual investors, PFMT, and NEPH
Boring isn't inactive, A New Add: $TRMR, Semler Update, 4 stocks on my watchlist: $BFIT, $NEPH, $LEE, $IDXG
See all

Medtech and Microcaps